Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 5488 of 6351
-
10,000 eczema patients enrolled in landmark Long-Term safety study
Knowledge-focused Recruiting nowThis prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for patients with atopic dermatitis under the care of a licensed dermatologist or qualified physician extender. Secondary object…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Smartphone app aims to prevent second strokes in high-risk patients
Disease control Stopped earlyProgram to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor (PACESETTER) aims to assess the incorporation of its stroke intervention into 2 safety net/academic health systems in a given US state especially burdened by str…
Sponsor: Northern California Institute of Research and Education • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New program aims to ease emotional burden of gynecologic cancer
Symptom relief OngoingThis study looks at how well the Journey Ahead intervention works in improving coping and communication skills in participants with gynecologic cancers.
Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Experimental lymphoma drug ASTX660 tested in tiny, terminated trial
Disease control Stopped earlyPhase 1 (dose-escalation part): Investigate the tolerability and safety of ASTX660 in patients with r/r PTCL and r/r CTCL and determine the recommended dose (RD) for the Phase 2. Phase 1 (ATLL expansion part): Evaluate the safety of ASTX660 at RD in patients with r/r ATLL. Phas…
Phase 1/2 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Migraine prevention drug trial in kids halted early
Prevention Stopped earlyThe aim of this study is to evaluate the effect of SPN-538 for the prophylaxis of migraine in pediatric patients 6 to 11 years old.
Phase 4 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Prevention
Last updated Jun 27, 2026 08:12 UTC
-
Anesthesia before age 10: does it harm Kids' brains?
Knowledge-focused Recruiting nowIn the past, a large number of animal studies have suggested that anesthesia exposure has potential neurotoxic effects, resulting in persistent cognitive and behavioral deficits. At present, there is still a lack of sufficient clinical research evidence to prove whether anesthesi…
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Could yoga and massage replace opioids for chronic pain?
Symptom relief CompletedThis study investigates how adults prescribed opioids for chronic noncancer pain respond to invitations to try non-opioid options of massage therapy, yoga therapy, chiropractic and physical therapies. Options will be available via telehealth consultation visits using a computer o…
Sponsor: Washington State University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Promising combo for tough breast cancer hits early snag
Disease control Stopped earlyThis phase II trial studies how well nab-paclitaxel and alpelisib works in treating patients with triple negative breast cancer with PIK3CA or PTEN alterations that does not respond to anthracycline chemotherapy (anthrocycline refractory). Drugs used in chemotherapy, such as nab-…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental myeloma drug tasquinimod tested in early trial – but study halted
Disease control Stopped earlyThis study is the first study of tasquinimod, an inhibitor of S100A9, in patients with multiple myeloma.
Phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Herbal capsule takes on hemorrhoid bleeding in major trial
Symptom relief CompletedA Phase III, randomized, double-blind, placebo-controlled clinical trial has been conducted to evaluate the efficacy and safety of Trĩ Thiên Dược capsules in people with grade II internal hemorrhoids with bleeding. This study aims to further assess the therapeutic effects and pot…
Phase 3 • Sponsor: Hanoi Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New study probes why stroke survivors struggle to sit steady
Knowledge-focused CompletedOne of the causes of disability in stroke patients is postural disturbances that result in postural asymmetry in the standing position, characterized during an evaluation on a force platform by a greater displacement of the center of pressure towards the lesion side and thus by a…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New nail for hip fractures tested in seniors
Knowledge-focused CompletedThis is an observational, prospective and multicenter clinical investigation that is part of the active materiovigilance plan that Orthofix Srl, in agreement with its Notified Body. The sponsor has planned to actively collect clinical data relating to the use of Chimaera Intramed…
Sponsor: Orthofix s.r.l. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Could a simple nutrient fix power plants in cells of septic shock patients?
Knowledge-focused Recruiting nowSeptic shock is defined as a subset of sepsis with severe metabolism alterations, leading to organ failure. Septic shock is associated with a high mortality, around 40% according to the SEPSIS 3 definition. Metabolic alterations are responsible for lactic acidosis, and results i…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Hemophilia drug safety under the microscope: real-world study launched
Knowledge-focused OngoingThe main aim of this study is to check for long-term side effects from ADYNOVI/ADYNOVATE prophylaxis in participants with haemophilia A when used under standard clinical practice in the real-world clinical setting.
Sponsor: Baxalta now part of Shire • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New study aims to simplify heart monitoring for pump patients
Diagnosis Recruiting nowLeft Ventricular Assist Device (LVAD) therapy has become a well-established treatment option for endstage heart-failure either as a bridge to transplant (BTT) or destination therapy (DT). Monitoring of the pump and with this the cardiac status with the HeartMate 3 (HM3) is curren…
Sponsor: Thomas Schlöglhofer, PhD, MSc • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
What matters most? new study puts quality of life first for older leukemia patients
Knowledge-focused OngoingThe purpose of this study is to describe the differences in quality of life (QOL) among newly diagnosed patients diagnosed with acute myeloid leukemia (AML) to help design a patient decision-making QOL model for aligning patients' choice of treatment with what matters the most to…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Seizure patterns may reveal hidden tumor changes
Knowledge-focused OngoingThis study investigates how seizures can vary over time with changes in low grade gliomas and its treatments. This study may help doctors find symptoms or triggers of seizures earlier than normal, and ultimately earlier care or treatment for seizures.
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Simple blood test may predict lymphoma treatment success
Knowledge-focused OngoingThe researchers are doing this study to measure and test cell-free DNA (cfDNA) in the blood before, during, and after first-line treatment for follicular lymphoma. They will look at whether cfDNA levels are related to a person's response to the usual first-line treatment for foll…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
COVID-19's hidden impact on blood clot recovery revealed
Knowledge-focused CompletedThe purpose of the study COVID-EP is to classify all the complications occurring after the diagnosis of pulmonary embolism in patients tested initially COVID-19 positive and negative by RT-PCR (on nasopharyngeal sample) during the peak of the pandemic in France (April 2020). The …
Sponsor: Hospital St. Joseph, Marseille, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New spinal implants under study for neck pain relief
Disease control By invitation onlyThe primary objective of this study is to evaluate the safety and performance of cervical spine surgery using interbody implants as measured by reported complications, radiographic outcomes, and patient-reported outcomes (PROs).
Sponsor: NuVasive • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC